GeneTex

  • Country / Location Selection

United States (US)

Cancer Tissue Gallery- GTX04408

MSH2 antibody [MSVA-902M] HistoMAX

 

Go to Normal Tissue Gallery Go back to product page Go to HistoMAX page

 

Breast – Invasive carcinoma of no special type (NST) showing strong MSH2 immunostaining in cancer cells.
Breast – Invasive lobular breast cancer with strong MSH2 immunostaining in cancer cells. Stromal cells and adjacent normal glands also show strong MSH2 positivity.
Colon – Colorectal adenocarcinoma showing a markedly reduced MSH2 immunostaining in cancer cells as compared to stromal and inflammatory cells
Colon – Colorectal adenocarcinoma with strong MSH2 immunostaining in cancer cells and in stromal cells.
Colon – Colorectal adenocarcinoma with strong MSH2 immunostaining in cancer cells and in stromal cells.
Colon – Colorectal adenocarcinoma with strong MSH2 immunostaining in cancer cells and in stromal cells.
Colon – Colorectal adenocarcinoma with strong MSH2 immunostaining in cancer cells and in stromal cells.
Colon – Colorectal adenocarcinoma with strong MSH2 immunostaining in stromal and inflammatory cells but absent MSH2 staining in cancer cells.
Esophagus – Squamous cell carcinoma exhibiting a strong MSH2 immunostaining in cancer cells and in stromal cells.
Ovary – Clear cell carcinoma showing strong MSH2 positivity in cancer cells and in stromal cells.
Ovary – Malignant Mixed Mullerian tumor with strong MSH2 positivity in cancer cells and in stromal cells.
Ovary – Malignant Mixed Mullerian tumor with strong MSH2 positivity in stromal and inflammatory cells but absence of staining in tumor cells.
Ovary – Serous high-grade carcinoma with strong MSH2 positivity in cancer cells and in stromal cells.
Pancreas – Adenocarcinoma of the ampulla Vaterii showing a strong MSH2 immunostaining in cancer cells and in stromal cells.
Pancreas – Ductal adenocarcinoma (perineural tumor growth) with strong MSH2 immunostaining in cancer cells and in stromal cells.
Pancreas – Ductal adenocarcinoma showing strong MSH2 immunostaining in cancer cells and in stromal cells.
Pancreas – Ductal adenocarcinoma with strong MSH2 positivity in cancer cells and in stromal cells.
Prostate – Adenocarcinoma (Gleason 3+3=6) with strong MSH2 immunostaining in cancer cells and in stromal cells.
Stomach – Gastric adenocarcinoma with strong MSH2 immunostaining in cancer cells and in stromal cells.
 

| TOP |